Cargando…
Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro
Immune-mediated damage to tumor vessels is a potential means of preventing solid tumor progression. Antiangiogenic cancer vaccines capable of inducing this kind of damage include formulations comprised of endothelial cell-specific antigens. Identification of antigens capable of eliciting efficient v...
Autores principales: | Lokhov, Petr G., Balashova, Elena E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667939/ https://www.ncbi.nlm.nih.gov/pubmed/23442592 http://dx.doi.org/10.4161/hv.22828 |
Ejemplares similares
-
Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens
por: Lokhov, Petr G., et al.
Publicado: (2010) -
Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)
por: Lokhov, Petr G, et al.
Publicado: (2015) -
Proteomic Footprinting of Drug-Treated Cancer Cells as a Measure of Cellular Vaccine Efficacy for the Prevention of Cancer Recurrence
por: Balashova, Elena E., et al.
Publicado: (2012) -
Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2016) -
SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2017)